BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 20374079)

  • 1. Serum and cerebrospinal fluid antioxidant activity and lipid peroxidation in Guillain-Barre syndrome and multiple sclerosis patients.
    Ghabaee M; Jabedari B; Al-E-Eshagh N; Ghaffarpour M; Asadi F
    Int J Neurosci; 2010 Apr; 120(4):301-4. PubMed ID: 20374079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Free radical toxicity and antioxidants in Guillain-Barre syndrome, a preliminary study.
    Kumar KT; Chandrika A; Sumanth KN; Sireesha P; Rao S; Rao A
    Clin Chim Acta; 2004 Aug; 346(2):205-9. PubMed ID: 15256322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered cerebrospinal fluid index of prealbumin, fibrinogen, and haptoglobin in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
    Zhang HL; Zhang XM; Mao XJ; Deng H; Li HF; Press R; Fredrikson S; Zhu J
    Acta Neurol Scand; 2012 Feb; 125(2):129-35. PubMed ID: 21434877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in cerebrospinal fluid levels of malondialdehyde and glutathione reductase activity in multiple sclerosis.
    Calabrese V; Raffaele R; Cosentino E; Rizza V
    Int J Clin Pharmacol Res; 1994; 14(4):119-23. PubMed ID: 7607784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid peroxidation and total antioxidant status in patients with breast cancer.
    Sener DE; Gönenç A; Akinci M; Torun M
    Cell Biochem Funct; 2007; 25(4):377-82. PubMed ID: 16447143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum total antioxidant status and lipid peroxidation marker malondialdehyde levels in overt and subclinical hypothyroidism.
    Torun AN; Kulaksizoglu S; Kulaksizoglu M; Pamuk BO; Isbilen E; Tutuncu NB
    Clin Endocrinol (Oxf); 2009 Mar; 70(3):469-74. PubMed ID: 18727709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of lipid peroxidation product, nitrite and antioxidant levels in newly diagnosed and two months follow-up patients with pulmonary tuberculosis.
    Lamsal M; Gautam N; Bhatta N; Toora BD; Bhattacharya SK; Baral N
    Southeast Asian J Trop Med Public Health; 2007 Jul; 38(4):695-703. PubMed ID: 17883009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total antioxidant status and lipid peroxidation in HIV-1 infected patients in a rural area of south western Nigeria.
    Ogunro PS; Ogungbamigbe TO; Ajala MO; Egbewale BE
    Afr J Med Med Sci; 2005 Sep; 34(3):221-5. PubMed ID: 16749352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour necrosis factor alpha, lipid peroxidation and NO* are increased and associated with decreased free-radical scavenging enzymes in patients with Weill-Marchesani syndrome.
    Evereklioglu C; Turkoz Y; Calis M; Duygulu F; Karabulut AB
    Mediators Inflamm; 2004 Jun; 13(3):165-70. PubMed ID: 15223607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Investigation of oxidative stress and antioxidant defense in patients with hepatitis B virus infection and the effect of interferon-alpha plus lamivudine combination therapy on oxidative stress].
    Acar A; Görenek L; Aydin A; Eyigün CP; Eken A; Sayal A; Pahsa A
    Mikrobiyol Bul; 2009 Jul; 43(3):411-23. PubMed ID: 19795616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-15 is elevated in serum and cerebrospinal fluid of patients with multiple sclerosis.
    Rentzos M; Cambouri C; Rombos A; Nikolaou C; Anagnostouli M; Tsoutsou A; Dimitrakopoulos A; Triantafyllou N; Vassilopoulos D
    J Neurol Sci; 2006 Feb; 241(1-2):25-9. PubMed ID: 16316662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analyses of transthyretin concentration in the cerebrospinal fluid of patients with Guillain-Barré syndrome and other neurological disorders.
    Chiang HL; Lyu RK; Tseng MY; Chang KH; Chang HS; Hsu WC; Kuo HC; Chu CC; Wu YR; Ro LS; Huang CC; Chen CM
    Clin Chim Acta; 2009 Jul; 405(1-2):143-7. PubMed ID: 19410571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypocretin-1 (orexin-A) concentrations in cerebrospinal fluid are low in patients with Guillain-Barré syndrome.
    Kanbayashi T; Ishiguro H; Aizawa R; Saito Y; Ogawa Y; Abe M; Hirota K; Nishino S; Shimizu T
    Psychiatry Clin Neurosci; 2002 Jun; 56(3):273-4. PubMed ID: 12047592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated terminal complement in cerebrospinal fluid in Guillain-Barré syndrome and multiple sclerosis.
    Sanders ME; Koski CL; Robbins D; Shin ML; Frank MM; Joiner KA
    J Immunol; 1986 Jun; 136(12):4456-9. PubMed ID: 3711661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of uric acid and gamma-glutamyltransferase on total antioxidant capacity and oxidative stress in patients with metabolic syndrome.
    Simão AN; Dichi JB; Barbosa DS; Cecchini R; Dichi I
    Nutrition; 2008; 24(7-8):675-81. PubMed ID: 18499396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presence of cytomegalovirus in cerebrospinal fluid of patients with Guillain-Barre syndrome.
    Steininger C; Popow-Kraupp T; Seiser A; Gueler N; Stanek G; Puchhammer E
    J Infect Dis; 2004 Mar; 189(6):984-9. PubMed ID: 14999600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative stress in patients with essential hypertension.
    Tandon R; Sinha MK; Garg H; Khanna R; Khanna HD
    Natl Med J India; 2005; 18(6):297-9. PubMed ID: 16483028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lipid peroxidation and activity of antioxidative enzymes in patients with multiple myeloma].
    Zima T; Spicka I; Stípek S; Crkovská J; Pláteník J; Merta M; Nĕmecek K; Tesar V
    Cas Lek Cesk; 1996 Jan; 135(1):14-7. PubMed ID: 8599825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum lipid peroxidation and antioxidant potential levels in hyperemesis gravidarum.
    Güney M; Oral B; Mungan T
    Am J Perinatol; 2007 May; 24(5):283-9. PubMed ID: 17514602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dendritic cells in the cerebrospinal fluid and peripheral nerves in Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
    Press R; Nennesmo I; Kouwenhoven M; Huang YM; Link H; Pashenkov M
    J Neuroimmunol; 2005 Feb; 159(1-2):165-76. PubMed ID: 15652416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.